The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1724-6059
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients ; day:19 ; month:9 ; year:2016 ; pages:1-9
Journal of nephrology ; (19.9.2016), 1-9
- Creator
-
Sibbel, Scott
- Contributor
-
Maroni, Bradley J.
Brunelli, Steven M.
SpringerLink (Online service)
- DOI
-
10.1007/s40620-016-0350-1
- URN
-
urn:nbn:de:1111-201610216616
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sibbel, Scott
- Maroni, Bradley J.
- Brunelli, Steven M.
- SpringerLink (Online service)
Other Objects (12)
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study
Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients
Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis
Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study
Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients
Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis
Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study
Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients
Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis
Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus